%0 Journal Article
%T A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab©\Paclitaxel and Gemcitabine in Advanced Solid Tumors
%A Afshin Eli Gabayan
%A Albert Assad
%A Daniel D. Von Hoff
%A Gregory L. Beatty
%A Huiling Zhen
%A Julie Switzky
%A Nikhil Uppal
%A Ross Donehower
%A Safi Shahda
%A Steven J. Cohen
%A Thaddeus Beck
%J Archive of "The Oncologist".
%D 2019
%R 10.1634/theoncologist.2017-0665
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324630/